Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why do adipocytes make the beta 3 adrenergic receptor?

J G Granneman1

  • 1Department of Psychiatry, Wayne State University School of Medicine, Detroit, MI 48201, USA.

Cellular Signalling
|January 1, 1995
PubMed
Summary

Adipocytes utilize multiple beta-adrenergic receptors, including the beta 3 subtype. This review contrasts beta 3 receptors with beta 1 and beta 2, highlighting differences in signaling and therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renaissance of brown adipose tissue research: integrating the old and new.

International journal of obesity supplements·2016
Same author

Cell Biology Symposium: imaging the organization and trafficking of lipolytic effectors in adipocytes.

Journal of animal science·2010
Same author

White adipose tissue contributes to UCP1-independent thermogenesis.

American journal of physiology. Endocrinology and metabolism·2003
Same author

Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism.

Journal of neurochemistry·2001
Same author

PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture.

Glia·2001
Same author

The putative beta4-adrenergic receptor is a novel state of the beta1-adrenergic receptor.

American journal of physiology. Endocrinology and metabolism·2001

Area of Science:

  • Pharmacology
  • Cell Biology
  • Endocrinology

Background:

  • Adipocytes express various beta-adrenergic receptor (BAR) subtypes, including beta 1, beta 2, and the recently identified beta 3 receptor.
  • The co-expression of multiple BAR subtypes in fat cells suggests distinct signaling roles for each receptor.

Purpose of the Study:

  • To review and contrast the properties of recombinant and natively expressed beta 3 receptors with beta 1 and beta 2 receptors.
  • To discuss the potential of the beta 3 receptor as a therapeutic target based on its unique characteristics and human tissue distribution.

Main Methods:

  • Review of existing literature on beta-adrenergic receptor properties.
  • Comparison of receptor coupling efficiency, G-protein coupling specificity, and agonist regulation across beta 1, beta 2, and beta 3 receptors.
  • Analysis of recent data on human tissue distribution of the beta 3 receptor.

Main Results:

  • Beta 3 receptors exhibit distinct properties compared to beta 1 and beta 2 receptors, including differences in receptor coupling efficiency and G-protein specificity.
  • Regulation of beta 3 receptors by agonist exposure appears to differ from other subtypes.
  • New data reveal specific tissue distribution patterns for the beta 3 receptor in humans.

Conclusions:

  • The unique signaling properties and tissue distribution of beta 3 receptors present opportunities for targeted therapeutic interventions.
  • Understanding the differential functions of BAR subtypes in adipocytes is crucial for metabolic research and drug development.

Related Experiment Videos